Organization, Description of Business and Liquidity and Capital Resources (Details) $ / shares in Units, $ in Thousands |
9 Months Ended | ||||
|---|---|---|---|---|---|
|
Jul. 28, 2023
USD ($)
|
Mar. 15, 2023 |
Mar. 03, 2023
$ / shares
|
Sep. 30, 2023
USD ($)
$ / shares
shares
|
Dec. 31, 2022
USD ($)
$ / shares
|
|
| Reverse stock split ratio | 0.0667 | ||||
| Preferred stock par value (in dollars per share) | $ / shares | $ 0.0001 | $ 0.0001 | $ 0.0001 | ||
| Number of fractional shares issued in connection with the Reverse Stock Split | shares | 0 | ||||
| Accumulated deficit | $ (372,355) | $ (329,369) | |||
| Amended Asset Purchase Agreement | uBriGene | |||||
| Asset purchase agreements, base consideration | $ 6,000 | ||||
| Asset purchase agreement, contingent consideration less severance obligation | $ 5,000 | ||||
| Number of years after the closing date | 2 years | ||||
| Maximum | |||||
| Reverse stock split ratio | 0.05 | ||||
| Minimum | |||||
| Reverse stock split ratio | 0.20 | ||||
| Minimum | Amended Asset Purchase Agreement | uBriGene | |||||
| Issuance of equity securities | $ 10,000 |
| X | ||||||||||
- Definition The amount of base consideration for sale of all of the Company's assets primarily relating to the Company's operations primarily relating to the manufacturing and production of cell and gene therapies to uBriGene. No definition available.
|
| X | ||||||||||
- Definition Amount contingent amount of $5.0 million less certain severance obligations and payments payable in connection with the transfer of certain contracts related to the transferred assets No definition available.
|
| X | ||||||||||
- Definition Amount of equity securities issued in pursuant to the Asset Purchase Agreement. No definition available.
|
| X | ||||||||||
- Definition The period of time after the closing date of Asset Purchase Agreement. No definition available.
|
| X | ||||||||||
- Definition Ratio applied to the conversion of reverse stock split, for example but not limited to, one share converted to two or two shares converted to one. No definition available.
|
| X | ||||||||||
- Definition Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of accumulated undistributed earnings (deficit). Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Reduction in the number of shares during the period as a result of a reverse stock split. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|